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Abstract 
Introduction: Pre-Exposure Prophylaxis (PrEP) is a once-daily medication introduced in 2012 
that is utilized in the realm of public health as an effective method HIV prevention. However, 
PrEP uptake has proven to be limited among high-risk populations, and the barriers to these 
persons face to uptake are just beginning to be researched. This study sought to understand the 
barriers that impede patients at risk of HIV that visited the Adult Sexual Health Clinic (AHC) of 
the Durham County Department of Public Health (DCoDPH) in North Carolina.  
 
Methods: This cross-sectional study utilized a structured, quantitative questionnaire to gather 
data from a sample of patients of the AHC that were identified as being at high-risk of HIV and 
did not meet their initial PrEP referral appointment. The questionnaire was constructed through a 
detailed review of the prior literature that exists on barriers to PrEP uptake, and the questionnaire 
was administered over the phone at the AHC via DCoDPH personnel in the April 2019  
 
Results: 10 of the 28 patients included within the study sample responded to reasons why they 
missed their first appointment, and 8 completed the entire questionnaire. Due to the number of 
respondents, the data collected had little statistical significance, but it produced important 
information about the perceptions of barriers to PrEP uptake among the AHC patients. Half 
(four) of the questionnaire respondents did not relate to any of the barriers to PrEP uptake that 
were identified from the existing literature, and the majority of respondents (six) reported 
patient-centered barriers to their first appointment PrEP appointment.  
 
Conclusions: There are barriers to PrEP uptake that are salient to the AHC patients and exist 
beyond the purview of prior literature. This study serves as a pilot study to an evolving 
investigation of barriers for persons at high risk of HIV living in Durham County. It 
demonstrates that as PrEP research develops, researchers will need to continue to evaluate and 
redefine what barriers exist for individuals within high-risk populations. 
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Introduction 
Pre-Exposure Prophylaxis (PrEP) is an effective Human Immunodeficiency Virus (HIV) 
prevention tool, 1 with over 90% efficacy in preventing infection 2 and the potential to 
significantly reduce the burden of HIV. 3 Yet, its widespread adoption among high-risk 
populations is limited, 4 owing to significant structural, economic and social barriers. 5-8 Nearly 
half of individuals identified as being at high risk for HIV referred to a PrEP provider do not 
come to their first appointment. 9 This gap on the PrEP care continuum significantly impairs the 
success of biomedical prevention efforts to reduce HIV incidence in the United States (U.S.). 5,10 
Our study sought to investigate the factors associated with poor PrEP uptake at the frontlines of 
HIV prevention at the Durham County Department of Public Health (DCDoPH), in Durham, 
North Carolina.  
Human Immunodeficiency Virus (HIV) disease is a life-altering and costly public health 
threat throughout the world. In the U.S., HIV is typically spread by having anal or vaginal sex or 
sharing injection drug equipment with someone who has HIV. 11 Innovations within the 
pharmaceutical industry have transformed HIV from a terminal illness to a lifelong, chronic 
condition, but HIV is still spreading rapidly. In March 2017, the CDC reported that, “The 
lifetime treatment cost of an HIV infection is estimated at $379,668 (in 2010 dollars)“. 12 In 
2015, approximately one million individuals in the U.S. were living with HIV, and an additional 
39,782 individuals were diagnosed in 2016. 13 North Carolina ranks 6th in the nation in number 
of new HIV cases, with 1,414 of the state’s residents receiving an HIV diagnosis in 2016. 13 Low 
testing rates and limited health care access underscores the impact of HIV as a public health 
epidemic; 1 in 7 individuals with HIV do not know that they have acquired it. 14  
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The CDC identifies men who have sex with men (MSM), Black and Latinx individuals, 
injection-drug users, and transgender individuals as high-risk populations for acquiring HIV. 15  
These populations carry a disproportionate burden of HIV in the U.S. 16 and are less often aware 
of their HIV infection. 17 The CDC found that the lifetime risk of an HIV diagnosis among Black 
MSM is 1 in 2 and 1 in 4 among Latinx MSM. 18 Sixty-eight percent of new HIV transmissions 
occur among MSM. 19 Among White MSM, diagnoses decreased by 10% in 2016, while 
increasing by 4% and 14% respectively, among Black and Latinx MSM. Simultaneously, 
population rates of new HIV diagnoses are highest in the Deep South (16.8 per 100,000 
compared to 7.5 per 100,000 in the Midwest). 19 HIV incidence is also highest among young 
persons, with incidence rates of 14,740 per 100,000 individuals age 20-29 in 2016. 19  
Pre-Exposure Prophylaxis (PrEP) is a once-daily drug therapy that can prevent the 
acquisition of HIV. 2 Truvada® from Gilead Sciences Inc. is the only FDA-approved once-daily 
medication form of PrEP. 20 When taken consistently, PrEP reduces the risk of HIV infection by 
up to 92%. 2 Additionally, PrEP uptake has been significantly associated with the decline of HIV 
in the United States from 2012 to 2016. 3 However, of the estimated 1.1 million persons with 
indications for PrEP, only 7% were on PrEP in 2016. 21 While the number of PrEP users 
increased by 470% in 2016, only 11.2% and 13.1% of those users were Black and Latinx, 
respectively. 21The social vulnerability to HIV infection among young, Black and Latinx MSM, 
injection drug users, and transgender individuals likely stems from a complex interplay of 
socioeconomic and cultural variables. 4,22 Addressing barriers to HIV prevention programs by 
tailoring interventions to populations at high risk of HIV has the potential to increase the reach 
and efficacy and public health efforts. 5,6  
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Barriers to PrEP uptake inhibit the efficacy of the public health interventions aimed to 
decrease HIV acquisitions. 5-8,10 Structural factors, such as insurance, costs and access to care, as 
well as social factors including relationship dynamics and stigma affect PrEP uptake and 
adherence. 23 Additional barriers to PrEP uptake among high-risk populations noted in prior 
studies include low perceived HIV risk, low perceived PrEP efficacy, and specific disparities 
across gender, racial and ethnic groups. 6 Although previous studies have employed a variety of 
methodologies in different research settings and locations to uncover barriers to PrEP uptake 
specific to high-risk populations, our review of these studies produced several thematic barriers 
to PrEP uptake, and these themes guided the creation of the research questionnaire used within 
our study (Table 1). In the following paragraphs, we present an explanation of each thematic 
barrier in tandem with relevant literature.  
 
Perceived Risk of HIV/ Perceived Benefit  
Low perceived risk of HIV likely plays a role in poor PrEP uptake. One study in 
Philadelphia (N=5,781) demonstrated this: “Two thirds of individuals testing positive and 87% 
of individuals testing negative assessed their own HIV risk as zero or low (p. 229).” 24 In a study 
conducted among high-risk individuals in Toronto, Canada, Rana et al. 25 reported low perceived 
risk of contracting HIV as the largest patient reported barrier to PrEP uptake, and Chan et al. 9 
uncovered the same conclusion studying MSM in Rhode Island. Both of these studies were 
conducted via public Sexually Transmitted Infections (STI) clinics and among high-risk 
individuals. Additionally, Whitfield et al. found lower perceived risk of HIV to be the most 
common reason for discontinuation of PrEP in a national survey. 26 Several studies report a lack 
of willingness to use PrEP because of low perceived risk of HIV. 27,28 Additionally, Biello et al. 
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discovered that limited HIV risk perception was an individual barrier to PrEP uptake within a 
series of qualitative interviews conducted injection drug users in Boston. 29 
 
Perceived Efficacy 
 Although clinical research as proven PrEP efficacious when taken at least four times a 
week, 30,31 a study by Golub et al. 8 provided evidence that high-risk populations may be 
concerned that PrEP does not provide complete protection against HIV transmission. This study 
included over 180 MSM and transgender women living in New York City, and its conclusions 
exemplify opinions of high-risk populations surrounding the benefits of PrEP. Participants 
presented with educational material about PrEP still endorsed concerns that PrEP did not provide 
complete HIV protection as one of the greatest barriers to uptake. Additionally, Underhill et al. 
remark that, “Prior research has found that willingness to use PrEP depends in part on perceived 
efficacy, with higher perceived efficacy predicting greater acceptability (p. 2).” 1 Research has 
shown that PrEP efficacy messaging delivery within clinical settings has proven to influence 
how high-risk patients understand the importance of PrEP, 1 highlighting the importance of 
provider attitudes and knowledge. Understanding how patients perceive PrEP’s ability to protect 
against HIV could inform efforts to increase uptake.  
 
Cost  
 Cost is an often-cited system-level barrier to PrEP uptake, affecting high-risk individuals 
32. However, research also demonstrates how cost can affect an individual’s decision to uptake 
PrEP. Whitfield et al. 26 analyzed survey responses about PrEP use and discontinuation among a 
national sample of 1,071 MSM on PrEP. Eighteen percent of survey participants discontinued 
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PrEP within the 24-month follow-up, and 30% of those participants reported cost or lack of 
insurance as a reason for discontinuing PrEP. Jaiswal et al. 5 found that participants identified 
paying for PrEP as a perceived barrier to uptake within a cross-sectional study of young sexual 
minority men (N=492, p < 0.05). Additionally, Goparaju et al. 7 found cost to be a perceived 
barrier to PrEP through focus groups conducted among HIV-negative women in Washington, 
D.C.  
Providers are also aware that insurance coverage and paying for PrEP is confusing to 
patients. Calabrese et al. 33 interviewed 18 experienced PrEP providers and reported that 
providers perceived navigating the requirements of private insurance, Medicaid, or Gilead 
patient assistance programs discouraging to patients attempting to initiate PrEP. Pinto et al. 32 
found lack of funding was the most consistently cited system-level barrier within a review of 47 
articles related to PrEP barriers.  
 
Side Effects 
 Literature suggests that patients at high risk of HIV may not begin PrEP because of 
concerns about potential side effects of PrEP and the risk of taking it with other medications. 
Mantel et al. 34 discovered within a street-based intercept survey including responses from 480 
MSM attending a New York Gay Pride Event that, “Men who thought that PrEP has a lot of side 
effects were the least likely to say they would use it (p. 3).” Bauermiester et al. 35 utilized an 
online, cross-sectional observational study examining 1,963 single YMSM’s partner-seeking 
experiences online between July 2012 and January 2013. They reported that, “When examining 
PrEP-related barriers among YMSM with prior PrEP knowledge (N=410), over a third (36.4%) 
agreed that they would not take PrEP due to side effect concerns (p. 7).” Additionally, results 
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from the iPrEx open label extension 36 indicate that almost half (49%) of individuals at high risk 
of HIV did not request PrEP due to concern about side effects.  
 
Appointments  
 The transportation and time necessary to travel to PrEP appointments, as well as time off 
from work or school, are barriers to PrEP uptake. Brinkley-Rubinstein et al. completed 
qualitative interviews among incarcerated gay, bisexual, and MSM in the Rhode Island 
Department of Corrections to gauge the prisoners’ knowledge and interest related to HIV and 
PrEP. Researchers also asked participants what barriers they would anticipate to PrEP uptake in 
their community. 37 Their study reported that, “Many participants discussed how lack of 
transportation was a concern post-release that may affect PrEP uptake (p. 6)”, and reaffirmed that 
prior research had also, “identified lack of access to transportation as a barrier for recently 
incarcerated individuals to receiving HIV care (p. 6).” Additionally, within a separate qualitative 
study completed by Biello et al. in the Northeastern United States, researchers discovered that, 
“Transportation and locations of services could also present challenges to PrEP access (p. 7)” 
among people who inject drugs (PWID). 29  Researchers have begun to respond to concerns of 
transportation as barrier to uptake by incorporating methods of free or subsidized transportation 
for study participants as well. 7,38  Additionally, Smith et al. 39 found that the convenience and 
ease of accessing PrEP services was a concern among young African American men and women 
18-24 years old at risk of HIV in Atlanta, Georgia through conducting qualitative interviews. 
Smith et al. provided comments that exemplified how participants perceived access to services 
via public transportation as a necessity to PrEP uptake. For example, one study participant 
claimed that, “If (the PrEP service location is) not within MARTA (Metropolitan Rapid Transit 
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Authority, public transportation), I’m not going go (p. 413).” 39 These research examples 
demonstrate how transportation is a barrier to PrEP uptake among a variety of populations at 
high risk of HIV.  
 
Stigma 
 Stigma surrounding sexual behavior and HIV has been documented as a barrier of PrEP 
uptake. Stigma stems from a variety of sources, including providers, family members, and 
society at large. Jaiswal et al. 5 found perceived stigma from providers to be a significant barrier 
to PrEP uptake among young sexual minority men, and online focus groups among 
geographically diverse MSM conducted by Maloney et al. 40 indicated that barriers to reducing 
perceived provider stigma included establishing more non-judgmental relationships with their 
providers. Additionally, Smith et al. found that stigma from family and peers was a barrier to 
PrEP uptake young African American adults at high-risk of HIV living in Atlanta, Georgia. 
Study participants claimed that they would anticipate negative reactions from peers and family 
members if they even found out they had been involved in an HIV medication study. 39  
Research conducted by Hubach et al. 42 reports that, “Addressing stigma situated across 
ecological levels in an effort to increase adoption of PrEP by MSM residing in rural states 
remains necessary (p. 315)”. However, research suggests that the influence of stigma as a barrier 
to PrEP uptake varies by geographic location. Cahill et al. 43 compared MSM experiences with 
PrEP between Jackson, Mississippi and Boston, Massachusetts. The study denoted that, “Jackson 
participants described stronger medical mistrust, and more frequently described experiences of 
anti-gay and HIV related stigma (p. 1)” and postulated that more affirming, culturally competent 
care could be a strategy to counteract stigma.  
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However, stigma towards PrEP is present even among persons at high-risk of HIV. Eaton 
et al. 41 completed a study among African American men and transgender women who have sex 
with men attending a pride festival in the Southeastern United States and discovered that, 
“Twenty-three percent (N = 60) of the sample believed that PrEP was for individuals who were 
promiscuous (p. 6)”. Additionally, they reported that, “This belief was associated with a lack of 
interest in using PrEP for all groups (p. 8)”. 41 This research demonstrates that internalized 
stigma towards PrEP among high-risk populations may also serve as a barrier to uptake.  
 
Daily Adherence  
At the time of this study, PrEP is only offered as a once-daily medication for HIV 
prevention. Although new methods of PrEP administration are being researched, such as long-
acting injectable PrEP, it will take time before such resources are available to public health 
departments. Young et al. 44 conducted focus groups and in-depth interviews in 2012 among gay, 
bisexual and men who have sex with men (MSM) and migrant African communities living in 
Scotland and discovered that maintaining regular adherence was a barrier to PrEP uptake. They 
report that, “Some participants described how they might forget to take tablets or their routine 
might be disrupted because of non-regular working patterns (p. 5).” 44 Their concerns are 
supported via data produced from the 1,603 HIV-negative men and transgender women who 
have sex with men within iPrEx open-label extension (iPrEx OLE). 36 Grant et al. found that 
24% of the study participants that chose not to receive PrEP identified the inconvenience of a 
daily pill as a barrier to uptake, and only 27% of those that opted to receive PrEP within the 
study achieved effective adherence levels (≥4 tablets per week). These results suggest that daily 
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PrEP adherence is both a barrier to PrEP uptake and efficacy of preventing HIV among high-risk 
populations.  
 
PrEP delivery in Durham County, North Carolina 
The DCoDPH Adult Health Clinic (AHC) is a walk-in, public clinic that provides testing 
and treatment for STIs, and referral services for PrEP. The AHC serves the greater Durham 
County community, a racially and culturally diverse county in North Carolina. In 2017, the 
Durham County population was 37.8% Black and 13.7% Latinx, with 16.1% in poverty. 45 The 
AHC serves a predominantly uninsured and under-insured population, and as such provides a 
vital service to Durham County. In addition, Durham County has the greatest prevalence rate of 
HIV in North Carolina. 46   
AHC providers identify high-risk individuals such as those who engage in condomless 
anal intercourse, sexual partners of people living with HIV, individuals who engage in 
transactional sex, and injection drug users who share injection equipment as potentially eligible 
for PrEP. These individuals are provided with education, individualized risk reduction 
counseling, and condoms. The AHC also administers initial testing and then refers eligible 
patients to providers within the Lincoln Community Health Center (LCHC), a Federal Qualified 
Health Center (FQHC) to initiate PrEP. The referral process is outlined in the DCoDPH PrEP 
referral policy document and based on validated PrEP referral methods. Despite this rigorous 
process, many patients identified as eligible for PrEP and provided with a referral to LCHC, do 
not attend their initial PrEP appointment. For example, from May 2015 to July 2016, 192 
individuals were referred to LCHC for PrEP initiation, but only 109 individuals attended an 
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initial appointment to initiate PrEP. The reasons for this are unknown but are presumably in line 
with other sexual health clinics in the U.S. 9 
The DCoDPH has structured their PrEP referral process to limit and address some 
barriers faced by patients of the AHC. For example, the DCoDPH program has addressed facets 
of the Purview Paradox, a significant barrier to PrEP uptake by engaging PrEP providers from 
the LCHC.  Despite these efforts, over 40% of individuals referred for PrEP ultimately do not 
come to their first PrEP appointment. This tremendously inhibits efforts to increase PrEP 
utilization. Through administering a brief structured questionnaire via telephone calls, this study 
seeks to understand factors that inhibit greater PrEP uptake among AHC patients through 
gathering and analyzing data pertaining to patient-perceived barriers among individuals that did 
not attend their PrEP appointment.  
There are a number of significant barriers to PrEP uptake that may play a role in 
preventing patients from coming to their first appointment for PrEP in Durham County, North 
Carolina. Our study sought to identify these barriers to inform improvements in the PrEP referral 
process at the DCDoPH, and ultimately decrease HIV incidence in Durham County.  
 
Methods 
Data Collection 
We administered a brief, structured telephone questionnaire to gather data regarding PrEP 
barriers. Patients referred to LCHC for PrEP but who did not attend their initial appointment 
were identified from DCoDPH patient records. Two hundred twenty-six patients were identified 
as being at high risk of HIV, and 89 (39%) did not meet their initial appointment; our study 
population (Figure 1). Of the 89 patients matching our inclusion criteria, 28 were selected to be 
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contacted by trained health department personnel contacted as members of our convenience 
sample. Basic demographic data of the 226 referred patients and the 28 individuals in the 
convenience sample was extracted from DCoDPH records into a separate spreadsheet. 
Demographic variables analyzed include the client’s gender, race, referral reason, and health 
insurance status. Data was de-identified using numerical identifiers, and a separate record 
containing only patient first name and telephone number was used to contact each patient. 
Patients were called by trained, designated investigators of the DCoDPH who conducted a brief 
structured telephone questionnaire with each patient to screen for potential barriers to getting on 
PrEP. Of the 28 individuals within our convenience sample, 10 persons responded, which 
produced a response rate of 36%. The questionnaire script is shown in Figure 2. Data gathered 
during the phone calls was recorded in a spreadsheet by the investigator, only using numerical 
identifiers. All materials for the study were stored in a HIPAA compliant manner and destroyed 
at the end of the study period. 
 
Measures 
Our research team developed this questionnaire based on barriers previously identified in 
PrEP uptake and implementation literature. Social scientists often rely upon theoretical 
frameworks of behavioral change to frame their understanding of why individuals do not adopt 
health prevention strategies. 47 Since we were trying to understand the motivations and 
inhibitions of why patients were not meeting their appointment, we utilized a theoretical model 
created to help explain and predict health-related behaviors to guide our research instrument. We 
utilized the Health Belief Model (HBM) as revised by Rosenstock et al. 48 to guide our 
questionnaire (Table 1). This revision of the HBM relies upon six concepts to rationalize an 
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individual’s behaviors: perceived susceptibility, perceived severity, perceived benefits, perceived 
barriers, cues to action, and self-efficacy. Each of the questions directly relates to a concept 
within the HBM framework, and data collected from our phone calls was analyzed in 
conjunction with this theoretical model as we explored why AHC patients are not initiating 
PrEP. Similar prior studies have retroactively applied HBM constructs. 10 However, by modeling 
our questionnaire through a validated and well-referenced theoretical framework we hope to 
provide a foundation for further study of the barriers to PrEP uptake at local health departments.  
The first segment of our questionnaire related to the HBM construct perceived benefits, 
by asking respondents “Do you believe you would benefit from PrEP?” If the respondent 
answered no, they were asked to evaluate whether a series of dichotomous statements apply to 
them that encompass perceived susceptibility, severity and benefits of taking PrEP (Table 1). 
However, if the respondent answers yes, they were directed to a separate segment of the 
questionnaire which relates to the HBM construct perceived barriers and self-efficacy. Finally, 
respondents were asked to reschedule their appointment, which addresses the concept of cues to 
action within the HBM framework. 
 
Statistical Analysis 
We analyzed the demographic characteristics and questionnaire responses of study 
participants using SAS ver 9.4 (SAS Institute, Inc., Cary, NC). We calculated percentages for 
demographic categories for the overall sample of referrals as well as those invited to complete 
the questionnaire. We also calculated percentages of responses for each question for those who 
completed the questionnaire. In our final analysis examining stated reasons for missing their first 
appointment, we coded qualitative responses into two categories, structural barriers (cost, 
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transportation to appointments, time off for appointments), and patient-centered barriers (forgot 
appointment, personal issues, prefers PCP to prescribe PrEP, still contemplating PrEP).  
 
Results 
Demographics of patients referred for PrEP  
Between May 2015 and February 2019, 266 patients were referred to Lincoln for PrEP, 
of which 226 were unique referrals (Table 2). The median age of these patients was 26 (range 
17-79). Of the 226 unique referrals, 188 (83%) identified as MSM and 11 (5%) as trans-
masculine, trans-feminine or nonbinary. Nineteen (8%) were cis-female. Fifty-five (24%) were 
having serodiscordant sex, of which 14 (6%) were non-MSM. Most were Black (58%), the 
remainder were White (22%), Hispanic (18%), or Asian (2%), and one was of unidentified race. 
Of the 226 patients, 48% were uninsured and 14% had Medicaid or Medicare, and the remainder 
(38%) had health insurance. 
 
Participant demographics 
A convenience sample of 28 patients was created from the 89 patients lost to follow up 
after their appointment at the AHC. Among the 28 patients in our sample, the median age was 26 
(range 19-57). Twenty-five (89%) were MSM, two (7%) were cis-female and two (7%) were 
trans. Seventeen (61%) were Black, four (14%) were White, six (21%) were Hispanic and one 
(4%) was Asian. Seventeen (61%) had health insurance, one (4%) had Medicaid or Medicare and 
10 (36%) were uninsured.  
 
Barriers to PrEP Uptake 
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Eight patients completed the questionnaire, and two additional patients were included in 
our data analysis because they provided a verbal reason for why they did not come to their 
appointment. However, responses related to barriers to PrEP were only gathered by the eight 
patients who completed the questionnaire (Table 3), and all of eight (100%) stated they thought 
they would benefit from PrEP. Seven (88%) of the eight participants requested a new 
appointment, while one patient did not want an appointment and stated it was because they are 
now in a monogamous relationship. Four patients (50%) reported no barriers to PrEP. Two 
(20%) reported difficulty getting time off from work or school, one (13%) reported 
transportation to appointments as a barrier and one (13%) reported cost as a barrier.  
 
Reasons for missed initial appointment 
Of the 10 patients who were reached, eight volunteered information about why they 
missed their initial appointment (Table 4). Two stated that they preferred getting PrEP from their 
PCP and not from the DCDoPH/Lincoln. One mentioned the cost of PrEP, one reported personal 
issues, one forgot their appointment, one reported difficulty getting off work for an appointment, 
one stated they did not have transportation to the appointment, and one was unsure if they were 
interested in PrEP.  
 
Discussion 
This pilot study, which included a small sample of patients referred for PrEP services, 
identified cost, transportation, and finding time for appointments as barriers to PrEP uptake. 
Many respondents did not identify with any of the barriers included within our questionnaire, but 
each respondent did supply a reason why they missed their first appointment. Their responses 
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demonstrate that some barriers to increasing PrEP uptake among high risk populations exist 
beyond the purview of prior literature.  
Patients referred for PrEP and patients included in the study sample had demographics 
more aligned with populations at high risk of HIV than persons living in Durham County, 
consistent with the DCDoPH PrEP referral policy. Among patients referred for PrEP services 
and those included within the study sample, most were black and cis-male, whereas Durham 
County residents are majority white and female. 46 Approximately half of the patients referred 
for PrEP were uninsured, which is far greater than the 12.8% uninsurance rate among individuals 
under 65 living in Durham County, 46 and a fourth of insured patients relied on a public 
insurance option. Ultimately, 226 patients were identified as being at high risk of HIV, and 89 
(39%) did not meet their initial appointment; our study population. The primary referral reason 
was that patients were MSM. Ten individuals (11% of the study population) provided reasons for 
not attending their initial PrEP appointment, which produced a sample response rate of 36%.  
Participants identified finding time to meet their appointments, cost and transportation as 
barriers to PrEP, and research has shown that populations at high risk of HIV face considerable 
socioeconomic challenges to receiving services. 4,22 This study demonstrates that respondents of 
our questionnaire did resonate with a few of the barriers identified within prior PrEP literature 
among similar, high-risk populations. 5,23,39 This suggests that prior literature was useful in 
identifying some of the barriers to PrEP uptake. However, lack of perceived benefit of PrEP was 
not a barrier to respondents of our questionnaire. Contrary to results in prior literature, 25 
respondents to our questionnaire unanimously believed that they could benefit from taking PrEP. 
Conducting a larger, comprehensive study in Durham County may assist in ruling out perceived 
benefit of PrEP as barrier to our target population. Additionally, half of the questionnaire 
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respondents did not identify with any of the barriers in the questionnaire. These finding suggests 
that barriers to PrEP uptake  exist that are more salient to the AHC patients that were not 
accounted for in our questionnaire. It also may suggest that the decision to start PrEP is complex 
and dependent upon a variety of personal, interpersonal and structural factors.  
 Based on our study, we recommend that future research utilize a qualitative instrument to 
capture data on barriers to PrEP uptake. This will allow researchers to produce a more holistic 
understanding of patient motivations and experiences with PrEP. The barriers included in prior 
literature do not encompass all of the barriers that persons at high risk of HIV face, but we 
recommend that they still be utilized as probes in future study questionnaires since they were 
able to assist in identifying some barriers in our study. Notably, appointment reminders and 
greater coordination among AHC providers and PCPs may be antidotes to some of the barriers 
we identified in our study, but personal beliefs and motivations of patients will continue to 
impact PrEP uptake. Additionally, responses regarding reasons why participants failed to meet 
their initial appointments provided insight about what barriers we could have included. For 
example, we did not include patient-centered barriers that respondents volunteered during the 
phone call, such as forgetting their appointment and still deciding on PrEP. Including these and 
similar patient-centered barriers will improve our existing study instrument and allow for a more 
accurate depiction of reasons why patients are not meeting their appointments and should be 
included in future studies. Our study suggests that increasing PrEP uptake will rely upon 
affecting barriers salient among high risk populations at both the intrapersonal (i.e. patient-
centered barriers) and societal (i.e. structural barriers) levels.    
In general, size of the population we strived to draw conclusions about was limited due to 
the specificity of our inclusion criteria; patients at high risk of HIV, referred for PrEP, and did 
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not meet their first appointment, but also limited by difficulty reaching participants by phone. 
The sample size of this study (N=28) was also limited by the time and resources of the 
DCoDPH, which faced greater, practical priorities during the course of our project. Though 
small, our study provided insights that can direct future PrEP research.  
Ultimately, this research serves as a pilot study to an evolving investigation of barriers 
among populations at high risk for HIV living in Durham County. These preliminary conclusions 
will be instrumental in conducting a more comprehensive study of barriers to PrEP uptake. 
Addressing barriers to PrEP uptake is crucial to decreasing new HIV transmissions. Thus, 
gaining and capitalizing on this knowledge is extremely important within the context of public 
health. This study demonstrates that as PrEP research develops, researchers will need to 
continuously redefine what barriers exist to individuals within their research populations. 
Subsequently, public health champions should expand and modify public health strategies in 
tandem with research as barriers to PrEP become further elucidated.  
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Figure 1. Sample selection.  
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Figure 2. Questionnaire script and algorithm.  
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Table 1. Questionnaire Items with HBM constructs and references.  
 
Statement Construct References 
Benefits of PrEP     
  I don’t think I’m at risk for HIV Perceived 
susceptibility 
Rana25, Ojikutu6, 
Whitfield26, Chan9 
  I don’t think getting HIV would be a big deal Perceived 
severity 
Yi49, Khumsaen50 
  I don’t think PrEP will actually help protect me 
from HIV 
Perceived 
benefits 
Golub8 
Barriers to PrEP      
  I don’t think I can get PrEP because I don’t have 
health insurance 
Perceived 
barriers 
Elopre51, Whitfield 
  I don’t think I can get PrEP because it would cost 
a lot of money 
Perceived 
barriers  
Jaiswal5, Calabrese52, 
Goparaju7 
 I don’t like to take meds, they have too many 
side effects 
Perceived 
barriers  
Cahill43, Chan 
  I can’t get off work/school to go to appointments Perceived 
barriers 
Golub, Traegeri 
  I don’t have a way to get to appointments Perceived 
barriers 
Elopre 
  I don’t feel comfortable talking to doctors about 
sex 
Perceived 
barriers 
Jaiswal, Maloney40, 
Cahill, Goparaju 
  I don’t think I could take a pill every day Self-efficacy Parsons53 
  I don’t think my friends/partners/family would 
approve 
Perceived 
barriers 
Pinto, Goparaju 
  I don’t want people to think I sleep around Perceived 
barriers 
Calabrese 
  I don’t want people to think I’m gay Perceived 
barriers 
Pinto 
Can we make an appointment for you?  Cue to action   
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Table 2. Demographic Characteristics of DCoDPH High-Risk Patients and Study Sample 
 
  
All 
referrals 
(N=226) 
% 
Lost to 
follow-up 
(N=28) 
% 
Median age 26   26   
Gender         
Cis-male 196 87% 24 86% 
Cis-female 19 8% 2 7% 
Queer/trans 11 5% 2 7% 
Race         
Black 131 58% 17 61% 
White 50 22% 4 14% 
Hispanic 40 18% 6 21% 
Asian 4 2% 1 4% 
Other 1 0%   0% 
Referral reason         
MSM 188 83% 25 89% 
Other 38 17% 3 11% 
Health insurance         
Insured 87 38% 17 61% 
Medicaid/Medicare 31 14% 1 4% 
Uninsured 108 48% 10 36% 
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Table 3. Reported barriers to PrEP.  
 
Barrier Number (%) 
None 4 (50) 
Time off for appointment 2 (25) 
Transportation 1 (12.5) 
Cost of PrEP 1 (12.5) 
 
 
Table 4. Reason for missing initial appointment.  
 
Reason Number 
Structural barriers   
  Cost of PrEP 1 
  Transportation to appointment 1 
  Time off from work/school 1 
Patient-centered barriers   
  Forgot 1 
  Personal issues 1 
  Prefers PCP 2 
  Still deciding on PrEP 1 
 
 
 
 
 
 
 
 
 
 
Zeagler, 25 
 
REFERENCES 
1. Underhill K, Morrow KM, Colleran C, et al. Explaining the Efficacy of Pre-exposure 
Prophylaxis (PrEP) for HIV Prevention: A Qualitative Study of Message Framing and 
Messaging Preferences Among US Men Who have Sex with Men. AIDS Behav. 
2016;20(7):1514-1526. 
2. Centers for Disease Control and Prevention USDoHaHS. Pre-Exposure Prophylaxis.  
https://www.cdc.gov/hiv/risk/prep/index.html. Accessed Nov 22, 2018. 
3. Sullivan PS, et al. The Impact of Pre-exposure Prophylaxis With FTC/TDF on HIV 
Diagnoses, 2012-2016, United States 22nd International AIDS Conference; 2018 Jul; 
A,msterdam, The Netherlands. 
4. Garcia J, Parker C, Parker RG, Wilson PA, Philbin M, Hirsch JS. Psychosocial 
Implications of Homophobia and HIV Stigma in Social Support Networks: Insights for 
High-Impact HIV Prevention Among Black Men Who Have Sex With Men. Health Educ 
Behav. 2016;43(2):217-225. 
5. Jaiswal J, Griffin M, Singer SN, et al. Structural Barriers to Pre-exposure Prophylaxis 
Use Among Young Sexual Minority Men: The P18 Cohort Study. Curr HIV Res. 
2018;16(3):237-249. 
6. Ojikutu BO, Bogart LM, Higgins-Biddle M, et al. Facilitators and Barriers to Pre-
Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results 
from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav. 
2018;22(11):3576-3587. 
Zeagler, 26 
 
7. Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. 
Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US 
Women. J AIDS Clin Res. 2017;8(9). 
8. Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy 
to effectiveness: facilitators and barriers to PrEP acceptability and motivations for 
adherence among MSM and transgender women in New York City. AIDS Patient Care 
STDS. 2013;27(4):248-254. 
9. Chan PA, Glynn TR, Oldenburg CE, et al. Implementation of Preexposure Prophylaxis 
for Human Immunodeficiency Virus Prevention Among Men Who Have Sex With Men 
at a New England Sexually Transmitted Diseases Clinic. Sex Transm Dis. 
2016;43(11):717-723. 
10. Felsher M, Szep Z, Krakower D, Martinez-Donate A, Tran N, Roth AM. "I Don't Need 
PrEP Right Now": A Qualitative Exploration of the Barriers to PrEP Care Engagement 
Through the Application of the Health Belief Model. AIDS Educ Prev. 2018;30(5):369-
381. 
11. U.S. Department of Health and Human Services. The basics of HIV prevention.  
https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/20/48/the-basics-of-hiv-
prevention. 
12. Centers for Disease Control and Prevention USDoHaHS. HIV Cost-Effectiveness.  
https://www.cdc.gov/hiv/programresources/guidance/costeffectiveness/index.html. 
Accessed Nov 22, 2018. 
13. Centers for Disease Control and Prevention USDoHaHS. Diagnoses of HIV Infection in 
the United States and Dependent Areas, 2016.  
Zeagler, 27 
 
https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-
2016-vol-28.pdf. 
14. U.S. Department of Health and Human Services. Overview: Data & Trends.  
https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics. 
15. Centers for Disease Control and Prevention USDoHaHS. Populations at Greatest Risk.  
https://www.cdc.gov/hiv/policies/hip/risk.html. 
16. Centers for Disease Control and Prevention USDoHaHS. HIV Among Youth.  
https://www.cdc.gov/hiv/group/age/youth/index.html. 
17. Wejnert C, Le B, Rose CE, Oster AM, Smith AJ, Zhu J. HIV infection and awareness 
among men who have sex with men-20 cities, United States, 2008 and 2011. PLoS One. 
2013;8(10):e76878. 
18. Lifetime Risk of HIV Diagnosis [press release]. February 23, 2016. 
19. Centers for Disease Control and Prevention USDoHaHS. HIV in the United States: At A 
Glance.  www.cdc.gov/hiv/statistics/overview/ataglance.html. 
20. Gilead Sciences. Truvada® (emtricitabine and tenofovir disoproxil fumarate). In. Foster 
City, CA2012. 
21. Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV Preexposure Prophylaxis, by 
Race and Ethnicity - United States, 2014-2016. MMWR Morb Mortal Wkly Rep. 
2018;67(41):1147-1150. 
22. Mustanski B, Morgan E, D'Aquila R, Birkett M, Janulis P, Newcomb ME. Individual and 
Network Factors Associated With Racial Disparities in HIV Among Young Men Who 
Have Sex With Men: Results From the RADAR Cohort Study. J Acquir Immune Defic 
Syndr. 2019;80(1):24-30. 
Zeagler, 28 
 
23. Arnold T, Brinkley-Rubinstein L, Chan PA, et al. Social, structural, behavioral and 
clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in 
Mississippi. PLoS One. 2017;12(2):e0172354. 
24. Nunn A, Zaller N, Cornwall A, et al. Low perceived risk and high HIV prevalence among 
a predominantly African American population participating in Philadelphia's Rapid HIV 
testing program. AIDS Patient Care STDS. 2011;25(4):229-235. 
25. Rana J, Wilton J, Fowler S, Hart TA, Bayoumi AM, Tan DHS. Trends in the awareness, 
acceptability, and usage of HIV pre-exposure prophylaxis among at-risk men who have 
sex with men in Toronto. Can J Public Health. 2018;109(3):342-352. 
26. Whitfield THF, John SA, Rendina HJ, Grov C, Parsons JT. Why I Quit Pre-Exposure 
Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP 
Discontinuation and Potential Re-initiation Among Gay and Bisexual Men. AIDS Behav. 
2018;22(11):3566-3575. 
27. Traeger L, O'Cleirigh C, Skeer MR, Mayer KH, Safren SA. Risk factors for missed HIV 
primary care visits among men who have sex with men. J Behav Med. 2012;35(5):548-
556. 
28. John SA, Rendina HJ, Grov C, Parsons JT. Home-based pre-exposure prophylaxis (PrEP) 
services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and 
persistence. PLoS One. 2017;12(12):e0189794. 
29. Biello KB, Bazzi AR, Mimiaga MJ, et al. Perspectives on HIV pre-exposure prophylaxis 
(PrEP) utilization and related intervention needs among people who inject drugs. Harm 
Reduct J. 2018;15(1):55. 
Zeagler, 29 
 
30. Elion R, Coleman M. The preexposure prophylaxis revolution: from clinical trials to 
routine practice: implementation view from the USA. Curr Opin HIV AIDS. 
2016;11(1):67-73. 
31. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV 
prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599. 
32. Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP Implementation 
Through Multilevel Interventions: A Synthesis of the Literature. AIDS Behav. 2018. 
33. Calabrese SK, Magnus M, Mayer KH, et al. "Support Your Client at the Space That 
They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-
Related Risk Compensation. AIDS Patient Care STDS. 2017;31(4):196-204. 
34. Mantell JE, Sandfort TG, Hoffman S, Guidry JA, Masvawure TB, Cahill S. Knowledge 
and Attitudes about Pre-Exposure Prophylaxis (PrEP) among Sexually Active Men Who 
Have Sex with Men (MSM) Participating in New York City Gay Pride Events. LGBT 
Health. 2014;1(2):93-97. 
35. Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and 
perceived barriers among single young men who have sex with men. Curr HIV Res. 
2013;11(7):520-527. 
36. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual 
practices, and HIV incidence in men and transgender women who have sex with men: a 
cohort study. Lancet Infect Dis. 2014;14(9):820-829. 
37. Brinkley-Rubinstein L, Peterson M, Arnold T, et al. Knowledge, interest, and anticipated 
barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men 
who have sex with men who are incarcerated. PLoS One. 2018;13(12):e0205593. 
Zeagler, 30 
 
38. Rolle CP, Rosenberg ES, Siegler AJ, et al. Challenges in Translating PrEP Interest Into 
Uptake in an Observational Study of Young Black MSM. J Acquir Immune Defic Syndr. 
2017;76(3):250-258. 
39. Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program 
preferences of African-American urban young adults about pre-exposure prophylaxis 
(PrEP). AIDS Educ Prev. 2012;24(5):408-421. 
40. Maloney KM, Krakower DS, Ziobro D, Rosenberger JG, Novak D, Mayer KH. 
Culturally Competent Sexual Healthcare as a Prerequisite for Obtaining Preexposure 
Prophylaxis: Findings from a Qualitative Study. LGBT Health. 2017;4(4):310-314. 
41. Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and 
Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using 
PrEP Among Black and White Men and Transgender Women Who Have Sex with Men. 
AIDS Behav. 2017;21(5):1236–1246. doi:10.1007/s10461-017-1690-0 
42. Hubach RD, Currin JM, Sanders CA, et al. Barriers to Access and Adoption of Pre-
Exposure Prophylaxis for the Prevention of HIV Among Men Who Have Sex With Men 
(MSM) in a Relatively Rural State. AIDS Educ Prev. 2017;29(4):315-329. 
43. Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical 
mistrust, and perceived racism may affect PrEP awareness and uptake in black compared 
to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS 
Care. 2017;29(11):1351-1358. 
44. Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis 
(PrEP) among communities most affected by HIV in the UK: findings from a qualitative 
study in Scotland. BMJ Open. 2014;4(11):e005717. 
Zeagler, 31 
 
45. Bureau USC. QuickFacts: Durham County, North Carolina. 2018; 
www.census.gov/quickfacts/durhamcountynorthcarolina. Accessed November 22, 2018. 
46. County Health Rankings & Roadmaps RWJF. 2018 North Carolina State Report. 2018; 
http://www.countyhealthrankings.org/explore-health-rankingsreports/state-
reports/2018/nortcarolina/. Accessed November 22, 2018. 
47. Schnall R, Rojas M, Travers J. Understanding HIV testing behaviors of minority 
adolescents: a health behavior model analysis. J Assoc Nurses AIDS Care. 
2015;26(3):246-258. 
48. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief 
Model. Health Educ Q. 1988;15(2):175-183. 
49. Yi H, Shidlo A, Sandfort T. Assessing maladaptive responses to the stress of being at risk 
of HIV Infection among HIV-negative gay men in New York City. J Sex Res. 
2011;48(1):62-73. 
50. Khumsaen N, Stephenson R. Beliefs and Perception About HIV/AIDS, Self-Efficacy, and 
HIV Sexual Risk Behaviors Among Young Thai Men Who Have Sex With Men. AIDS 
Educ Prev. 2017;29(2):175-190. 
51. Elopre L, Kudroff K, Westfall AO, Overton ET, Mugavero MJ. Brief Report: The Right 
People, Right Places, and Right Practices: Disparities in PrEP Access Among African 
American Men, Women, and MSM in the Deep South. J Acquir Immune Defic Syndr. 
2017;74(1):56-59. 
52. Calabrese SK, Underhill K, Earnshaw VA, et al. Framing HIV Pre-Exposure Prophylaxis 
(PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from 
Diminishing Public Support. AIDS Behav. 2016;20(7):1499-1513. 
Zeagler, 32 
 
53. Parsons JT, Rendina HJ, Lassiter JM, Whitfield TH, Starks TJ, Grov C. Uptake of HIV 
Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the 
United States. J Acquir Immune Defic Syndr. 2017;74(3):285-292. 
 
 
 
 
